Publisher's Synopsis
As many as 250,000 people in the United States have dystonia, making it the third most common movement disorder following essential tremor and Parkinson's disease. This authoritative reader-friendly resource provides a wide-ranging overview of the latest research and developments regarding the pathogenesis, evaluation, and management of the disease. Providing detailed coverage of every available treatment option for dystonia including four categorized sections on medical management, botulinum toxin injections, phenol or neurolytic therapy, and surgical intervention, this source summarizes what is known about the disorder and dramatically improves the recognition and understanding of this debilitating disease.
